GW&K Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,979,464
| Closed | -$38.5M | – | 301 |
|
|
2018
Q1 | $38.5M | Buy |
1,979,464
+119,540
| +6% | +$2.35M | 0.65% | 42 |
|
|
2017
Q4 | $31M | Buy |
1,859,924
+1,108,348
| +147% | +$20.3M | 0.53% | 74 |
|
|
2017
Q3 | $15.3M | Sell |
751,576
-3,289
| -0.4% | -$62.9K | 0.25% | 159 |
|
|
2017
Q2 | $12.2M | Sell |
754,865
-22,230
| -3% | -$328K | 0.21% | 163 |
|
|
2017
Q1 | $9.83M | Buy |
777,095
+23,142
| +3% | +$280K | 0.19% | 167 |
|
|
2016
Q4 | $9.99M | Sell |
753,953
-146,480
| -16% | -$2.5M | 0.19% | 167 |
|
|
2016
Q3 | $21.3M | Sell |
900,433
-16,890
| -2% | -$454K | 0.4% | 110 |
|
|
2016
Q2 | $26.4M | Buy |
917,323
+143,350
| +19% | +$4.67M | 0.55% | 79 |
|
|
2016
Q1 | $24.8M | Buy |
773,973
+728,678
| +1,609% | +$25.6M | 0.55% | 80 |
|
|
2015
Q4 | $1.94M | Buy |
45,295
+1,350
| +3% | +$53.9K | 0.05% | 190 |
|
|
2015
Q3 | $1.55M | Buy |
43,945
+10,525
| +31% | +$474K | 0.04% | 190 |
|
|
2015
Q2 | $1.53M | Sell |
33,420
-695
| -2% | -$33K | 0.03% | 197 |
|
|
2015
Q1 | $1.6M | Buy |
+34,115
| New | +$1.36M | 0.04% | 197 |
|
GW&K Investment Management's IPXL Position: Q2 2018 in Review
GW&K Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,979,464 shares — an estimated $38.5M sold.
GW&K Investment Management first reported a position in IPXL in Q1 2015 and held it in 13 quarters. The position peaked at $38.5M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- GW&K Investment Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- GW&K Investment Management sold 1,979,464 Impax Laboratories, Inc. shares in Q2 2018, an estimated $38.5M.
- GW&K Investment Management first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 13 quarters.
- GW&K Investment Management's Impax Laboratories, Inc. position peaked at $38.5M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on GW&K Investment Management's 13F filing for Q2 2018, filed 7 Aug 2018.